For weight management, NICE recommends tirzepatide only within specialist weight management services for adults with a BMI of at least 35 kg/m (or at least 30 kg/m with weight-related comorbidities) and specific additional criteria
2 A literatura sobre o composto em humanos majoritariamente anedtica ou proveniente de estudos de fase I/II com foco em tolerabilidade, no em eficcia robusta
Buse JB, Henry RR, Han J, et al
*If Wegovy is commercially unavailable and listed on the FDA shortage list, our doctors may prescribe compounded semaglutide, the active ingredient in Wegovy, if deemed appropriate
To view or add a comment, sign in This mornings #HCAATPASummit session on pharmacogenomics featuring Nick Glimcher was a reminder that prescribing medication doesnt always have to be trial and error